Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emaxitinib sulfate tablets with or without SHR0302 gel in non-segmental vitiligo
CTR20254627Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivarmacitinib in Vitiligo, sponsored by Hengrui Therapeutics. Started Dec 2025; status: active.
02
Drugs
ivarmacitinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20254627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254627.